Tuesday, January 3, 2017

BRIEF-Glenmark pharmaceuticals receives FDA clearance of Ind for GBR 1302-beat phase I trial

* Glenmark pharmaceuticals receives fda clearance of ind for

gbr 1302-beat phase i trial

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)